Agenda

Vascular Intervention
& Stroke Innovation
thrOugh
Neuroimaging

*The program is preliminary and could be subject to changes

 7:00 – 8:00 am

FULL BREAKFAST PROVIDED

8:00 – 8:15 am

INAUGURATION OF ACADEMIA/INDUSTRY ROUNDTABLE ON VASCULAR INTERVENTION & STROKE INNOVATION THROUGH NEURODIAGNOSTICS

Chairs: David Liebeskind, UCLA
Max Wintermark, The University of Texas MD Anderson Center

08:15 – 10:05 am

SESSION 1: MOBILE NEURODIAGNOSTICS FOR STROKE DETECTION AND MANAGEMENT

Prehospital and ICU Paradigms for Stroke Diagnoses
Mobile Use of Standard Imaging: Prehospital CT Imaging
Mobile Use of Standard Imaging: MRI imaging in the ICU
Panel Discussion (Academia, Industry, FDA, CMS)

10:05-10:25 am

REFRESHMENT BREAK

10:25 – 12:15 pm

SESSION 2: STROKE CHARACTERIZATION AND QUANTIFICATION

To Quantify or Not to Quantify: Does Size Matter?
Stroke Characterization and Quantification: CT Approach
Stroke Characterization and Quantification: MRI Approach
Panel Discussion (Academia, Industry, FDA, CMS)

12:15 – 1:15 pm

LUNCH BREAK

1:15 – 3:05 pm

SESSION 3: NEUROIMAGING EVALUATION IN THERAPEUTIC DRUG/DEVICE DEVELOPMENT 

Which one matters most: Therapeutic Response or Clinical Outcome
Use of Automated and Standard Imaging Interpretation to predict Therapeutic Response
Imaging Core Lab Methodology and Functions for Clinical Trials
Panel Discussion (Academia, Industry, FDA, CMS)

3:05 – 3:25 pm

REFRESHMENT BREAK

3:25 – 5:15 pm

SESSION 4: NEUROIMAGING FOR HEMORRHAGE DETECTION

Definitions of Hemorrhagic Transformation: What Matters?
Imaging of Hemorrhagic Transformation: Implications for Clinical Practice
Balancing Safety: The Role of Devices and Drugs in Hemorrhagic Transformation
Panel discussion (Academia, Industry, FDA, CMS)

6:30 – 9:30 pm

EVENING OF NETWORKING:BUILIDING CONNECTIONS AND OPPORTUNITIES FOLLOWED BY SPECIAL PRESENTATION

  7:00 – 8:00 am

FULL BREAKFAST PROVIDED

  8:00 – 10:45 am

WORKSHOPS TO DEVELOP CONSENSUS RECOMMENDATIONS

Participants are divided into three groups – each to develop recommendations for

planned publication in a major scientific journal.

WORKSHOP #1: MOBILE STROKE DIAGNOSIS

WORKSHOP #2: STROKE IMAGING MEASURE OF THERAPEUTIC IMPACT

WORKSHOP #3: EVOLVING DEFINITIONS OF HEMORRHAGIC TRANSFORMATION

  10:45 – 11:00 am

REFRESHMENT BREAK

  11:00 am – 12:00 pm

WORKSHOP CHAIRS PRESENT RECOMMENDATIONS TO FULL ASSEMBLY DRAFTING OF CONSENSUS STATEMENT IS INITIATED 

  12:00 pm – 12:15 pm

CLOSING COMMENTS AND ADJOURNMENT